Bio-Techne (TECH) Operating Margin (2009 - 2026)
Bio-Techne (TECH) posted quarterly Operating Margin of 24.24% for Q1 2026, up 1200.0% year-over-year from 1.86% in Q1 2025, and up 31.71% quarter-over-quarter from 18.41% in Q4 2025.
Bio-Techne (TECH) Operating Margin (2009 - 2026) Analysis & Trends
Bio-Techne's Operating Margin history runs 18 years deep, the most recent figure standing at 24.24% for Q1 2026.
- In Q1 2026, Operating Margin rose 1200.0% year-over-year to 24.24%; the TTM figure through Mar 2026 stood at 12.7% (down 153.0% YoY), while the FY2025 annual figure was 8.38%, down 945.0% from the prior year.
- Operating Margin for Q1 2026 stood at 24.24%, up from 18.41% in the prior quarter.
- The five-year high for Operating Margin was 2815.85% in Q3 2022, with the low at 7.53% in Q2 2025.
- The 5-year median for Operating Margin is 20.17% (2023), against an average of 183.74%.
- The sharpest annual moves came in 2022 and 2023: Operating Margin surged 279132 bps in 2022, then sank 279568 bps in 2023.
- Bio-Techne's Operating Margin stood at 25.0% in 2022, then sank by 44 bps to 13.94% in 2023, then climbed by 15 bps to 15.96% in 2024, then grew by 15 bps to 18.41% in 2025, then jumped by 32 bps to 24.24% in 2026.
- Business Quant data shows TECH's Operating Margin at 24.24% in Q1 2026, 18.41% in Q4 2025, and 16.63% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -105.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 24.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.24% |
| Dec 31, 2025 | 18.41% |
| Sep 30, 2025 | 16.63% |
| Jun 30, 2025 | -7.53% |
| Mar 31, 2025 | 12.24% |
| Dec 31, 2024 | 15.96% |
| Sep 30, 2024 | 13.81% |
| Jun 30, 2024 | 14.97% |
| Mar 31, 2024 | 22.08% |
| Dec 31, 2023 | 13.94% |
| Sep 30, 2023 | 20.17% |
| Jun 30, 2023 | 31.37% |
| Mar 31, 2023 | 27.27% |
| Dec 31, 2022 | 25.00% |
| Sep 30, 2022 | 2,815.85% |
| Jun 30, 2022 | 27.95% |
| Mar 31, 2022 | 31.15% |
| Dec 31, 2021 | 23.15% |
| Sep 30, 2021 | 24.53% |
| Jun 30, 2021 | 26.48% |